US Stock MarketDetailed Quotes

ZVSAW ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM)

Watchlist
  • 0.070
  • 0.0000.00%
Close Dec 20 16:00 ET
0Market Cap0.00P/E (TTM)

ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(FY)Dec 31, 2020
Assets
Current assets
Cash, cash equivalents and short term investments
--31.47K
88.12%328.58K
--328.58K
--174.67K
-Cash and cash equivalents
--31.47K
88.12%328.58K
--328.58K
--174.67K
Prepaid assets
--1.42M
193.85%483.2K
--483.2K
--164.44K
Restricted cash
--297.35K
----
----
----
Total current assets
--1.75M
139.39%811.78K
--811.78K
--339.11K
Non current assets
Net PPE
--22.53K
-27.27%27.73K
--27.73K
--38.13K
-Gross PPE
--22.53K
0.00%52K
--52K
--52K
-Accumulated depreciation
----
-75.00%-24.27K
---24.27K
---13.87K
Non current prepaid assets
--166.66K
-7.03%286.66K
--286.66K
--308.32K
Total non current assets
--189.19K
-9.26%314.39K
--314.39K
--346.46K
Total assets
--1.94M
64.27%1.13M
--1.13M
--685.57K
Liabilities
Current liabilities
Payables
--4.2M
-13.49%2M
--2M
--2.31M
-accounts payable
--4.2M
-13.49%2M
--2M
--2.31M
Current accrued expenses
--1.55M
-35.25%748.77K
--748.77K
--1.16M
Current debt and capital lease obligation
--9.19M
329.63%9.15M
--9.15M
--2.13M
-Current debt
--9.19M
329.63%9.15M
--9.15M
--2.13M
Current deferred liabilities
--13.77K
-17.51%16.91K
--16.91K
--20.5K
Other current liabilities
--2.2M
-11.78%1.71M
--1.71M
--1.94M
Current liabilities
--17.16M
80.33%13.63M
--13.63M
--7.56M
Non current liabilities
Long term debt and capital lease obligation
----
----
----
--1.69M
-Long term debt
----
----
----
--1.69M
Total non current liabilities
--0
--0
--0
--1.69M
Total liabilities
--17.16M
47.42%13.63M
--13.63M
--9.24M
Shareholders'equity
Share capital
--243
0.00%242
--242
--242
-common stock
--242
0.00%242
--242
--242
-Preferred stock
--1
--0
--0
--0
Retained earnings
---58.65M
-18.04%-52.9M
---52.9M
---44.81M
Paid-in capital
--43.1M
11.53%40.07M
--40.07M
--35.92M
Other equity interest
--331.33K
0.00%331.33K
--331.33K
--331.33K
Total stockholders'equity
---15.22M
-46.07%-12.5M
---12.5M
---8.56M
Total equity
---15.22M
-46.07%-12.5M
---12.5M
---8.56M
Currency Unit
USD
USD
USD
USD
(Q2)Jun 30, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(FY)Dec 31, 2020
Assets
Current assets
Cash, cash equivalents and short term investments --31.47K88.12%328.58K--328.58K--174.67K
-Cash and cash equivalents --31.47K88.12%328.58K--328.58K--174.67K
Prepaid assets --1.42M193.85%483.2K--483.2K--164.44K
Restricted cash --297.35K------------
Total current assets --1.75M139.39%811.78K--811.78K--339.11K
Non current assets
Net PPE --22.53K-27.27%27.73K--27.73K--38.13K
-Gross PPE --22.53K0.00%52K--52K--52K
-Accumulated depreciation -----75.00%-24.27K---24.27K---13.87K
Non current prepaid assets --166.66K-7.03%286.66K--286.66K--308.32K
Total non current assets --189.19K-9.26%314.39K--314.39K--346.46K
Total assets --1.94M64.27%1.13M--1.13M--685.57K
Liabilities
Current liabilities
Payables --4.2M-13.49%2M--2M--2.31M
-accounts payable --4.2M-13.49%2M--2M--2.31M
Current accrued expenses --1.55M-35.25%748.77K--748.77K--1.16M
Current debt and capital lease obligation --9.19M329.63%9.15M--9.15M--2.13M
-Current debt --9.19M329.63%9.15M--9.15M--2.13M
Current deferred liabilities --13.77K-17.51%16.91K--16.91K--20.5K
Other current liabilities --2.2M-11.78%1.71M--1.71M--1.94M
Current liabilities --17.16M80.33%13.63M--13.63M--7.56M
Non current liabilities
Long term debt and capital lease obligation --------------1.69M
-Long term debt --------------1.69M
Total non current liabilities --0--0--0--1.69M
Total liabilities --17.16M47.42%13.63M--13.63M--9.24M
Shareholders'equity
Share capital --2430.00%242--242--242
-common stock --2420.00%242--242--242
-Preferred stock --1--0--0--0
Retained earnings ---58.65M-18.04%-52.9M---52.9M---44.81M
Paid-in capital --43.1M11.53%40.07M--40.07M--35.92M
Other equity interest --331.33K0.00%331.33K--331.33K--331.33K
Total stockholders'equity ---15.22M-46.07%-12.5M---12.5M---8.56M
Total equity ---15.22M-46.07%-12.5M---12.5M---8.56M
Currency Unit USDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg